Home・Lista de Ações・Becton Dickinson and Co

Becton Dickinson and Co

Fechado

SetorSaúde

170.18 0.05

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

165.89

Máximo

170.71

Indicadores-chave
By Trading Economics
Rendimento	-692M -310M
Vendas	-538M 4.7B
P/E Médio do Setor	29.705 68.51
EPS	2.9
Rendimento de Dividendos	2.52
Margem de lucro	-6.576
Funcionários	60,000
EBITDA	-499M 709M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+5.49% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	2.52% 2.29%
Próximos Ganhos	6 de ago. de 2026
Próxima data de dividendos	30 de set. de 2026
Próxima data de ex-dividendo	9 de set. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	4B 46B
Abertura anterior	170.13
Fecho anterior	170.18

Becton Dickinson and Co Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de ago. de 2026, 23:16 UTC

Becton Dickinson shares higher in after-market trading, reflecting positive market sentiment amid falling crude oil prices and expectations of reduced inflationary pressures.

3 de ago. de 2026, 22:51 UTC

Becton Dickinson shares are lower in after-market trading, influenced by a significant downturn in the Health Care Equipment sub-sector.

31 de jul. de 2026, 19:46 UTC

Becton Dickinson is higher today, showing resilience amid rising bond yields and inflation concerns. The stock remains above its 20-day moving average.

30 de jul. de 2026, 22:51 UTC

Becton Dickinson and Co shares are lower in after-hours trading, reflecting broader weakness in the Health Care Equipment sub-sector.

29 de jul. de 2026, 23:56 UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining momentum from Wednesday's close amid uncertainty over future interest rate decisions.

28 de jul. de 2026, 20:02 UTC

News

UBS initiated coverage of Becton Dickinson with a Buy rating and $190 price target, contributing to the stock's upward movement this week.

27 de jul. de 2026, 20:06 UTC

Becton Dickinson shares are higher, reflecting strength near the upper end of their one-month range amid falling oil prices and declining Treasury yields.

24 de jul. de 2026, 19:26 UTC

Becton Dickinson and Co is trading higher, supported by gains in the Health Care Equipment sub-sector and maintaining a position above its 20-day moving average.

23 de jul. de 2026, 19:56 UTC

Becton Dickinson shares are lower, extending a five-session decline amid ongoing market concerns over corporate earnings and inflation pressures from rising oil prices.

21 de jul. de 2026, 19:36 UTC

Becton Dickinson is trading lower today, extending a trend of three consecutive daily declines. No specific news was identified to explain the movement.

20 de jul. de 2026, 20:14 UTC

Becton Dickinson remains roughly flat in after-market trading, positioned 1.12% above its 20-day moving average, but has declined for three consecutive sessions.

Comparação entre Pares

Variação de preço

Becton Dickinson and Co Previsão

Preço-alvo

By TipRanks

5.49% parte superior

Previsão para 12 meses

Média 179.56 USD 5.49%

Máximo 204 USD

Mínimo 161 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Becton Dickinson and Co - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

9 ratings

Comprar

Manter

Vender

Com base em 9 analistas que deram avaliações de ações para Becton Dickinson and Co - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.